KROS · Keros Therapeutics, Inc. · Documents
Market Cap
$224.44M
Shares
19.83M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| 8-K | 2026-09-08 | — | |
| 10-Q | 2026-08-03 | 2026-06-30 | |
| 8-K | 2026-08-03 | — | |
| 8-K | 2026-08-03 | — | |
| 8-K | 2026-07-30 | — | |
| 8-K | 2026-07-22 | 2026-07-17 | |
| 8-K | 2026-06-25 | 2026-06-23 | |
| Investor Event Transcript | 2026-06-08 | 2026-06-30 | |
| 8-K | 2026-06-03 | — | |
| 8-K | 2026-06-01 | — | |
| 8-K | 2026-05-14 | — | |
| 10-Q | 2026-05-14 | 2026-03-31 | |
| DEF 14A | 2026-04-22 | 2026-06-03 | |
| 8-K | 2026-03-09 | — | |
| 8-K | 2026-03-04 | — | |
| 8-K | 2026-03-04 | — | |
| 10-K | 2026-03-04 | 2025-12-31 | |
| 8-K | 2026-02-26 | 2026-02-20 | |
| 8-K | 2026-02-18 | — | |
| 8-K | 2026-01-09 | — | |
| 8-K | 2025-11-05 | — | |
| 10-Q | 2025-11-05 | 2025-09-30 | |
| 8-K | 2025-10-15 | — | |
| 8-K | 2025-09-08 | — | |
| 8-K | 2025-08-28 | — | |
| 8-K | 2025-08-20 | — | |
| 10-Q | 2025-08-06 | 2025-06-30 | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-08-06 | — | |
| 8-K | 2025-07-17 | — | |
| 8-K | 2025-07-15 | 2025-07-09 | |
| 8-K | 2025-06-09 | 2025-06-04 | |
| 8-K | 2025-06-06 | — | |
| 8-K | 2025-05-29 | 2025-05-28 | |
| 8-K | 2025-05-12 | — | |
| 10-Q | 2025-05-06 | 2025-03-31 | |
| 8-K | 2025-05-06 | — | |
| DEF 14A | 2025-04-23 | 2025-06-04 | |
| 8-K | 2025-04-18 | 2025-04-17 | |
| 8-K | 2025-04-10 | 2025-04-09 | |
| 8-K | 2025-03-31 | — | |
| 8-K | 2025-03-06 | 2025-03-05 | |
| 8-K | 2025-02-28 | — | |
| 8-K | 2025-02-26 | — | |
| 10-K | 2025-02-26 | 2024-12-31 | |
| 8-K | 2025-01-30 | — | |
| 8-K | 2025-01-21 | 2025-01-16 | |
| 8-K | 2025-01-15 | — | |
| 8-K | 2025-01-10 | — | |
| 8-K | 2024-12-12 | — |
Showing 1–50 of 185 filings
Key facts
CIK
1664710
CUSIP
492327101
13F (30d)
94 filings
94 filers
Visit website
Investor relations